Alkem Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	147,123	129,645	126,676	115,993	106,342
Revenue Growth	13.48%	2.34%	9.21%	9.07%	19.96%
Cost of Revenue	50,928	49,255	50,642	50,207	42,806
Gross Profit	96,195	80,391	76,034	65,785	63,536
Selling, General & Admin	28,371	32,422	30,324	29,726	25,769
Other Operating Expenses	37,772	22,879	23,041	19,760	17,305
Operating Expenses	69,964	58,873	56,359	52,589	46,103
Operating Income	26,232	21,518	19,676	13,196	17,432
Interest Expense	-1,608	-1,048	-970.8	-809.2	-308.9
Interest & Investment Income	-	3,588	2,758	1,711	1,227
Earnings From Equity Investments	-19.7	-6.2	-	-	-
Currency Exchange Gain (Loss)	-	380	-335.1	-188.6	-16.5
Other Non Operating Income (Expenses)	5,834	239.6	179.2	-12.8	-24.2
EBT Excluding Unusual Items	30,438	24,671	21,307	13,897	18,309
Gain (Loss) on Sale of Investments	-	528.9	151.7	308.6	114.5
Gain (Loss) on Sale of Assets	-	46	-31.8	-123.6	19.7
Asset Writedown	-747	-137.3	-576.5	-1,051	-11.2
Other Unusual Items	-1,001	155.1	-618.6	17.4	10.5
Pretax Income	28,689	25,264	20,231	13,048	18,443
Income Tax Expense	5,178	3,110	2,117	2,980	1,640
Earnings From Continuing Operations	23,512	22,154	18,115	10,068	16,803
Minority Interest in Earnings	-493.6	-499	-156.9	-226.4	-347
Net Income	23,018	21,655	17,958	9,842	16,456
Net Income to Common	23,018	21,655	17,958	9,842	16,456
Net Income Growth	6.30%	20.59%	82.47%	-40.20%	3.82%
Shares Outstanding (Basic)	120	120	120	120	120
Shares Outstanding (Diluted)	120	120	120	120	120
Shares Change	0.00%	-	-	-	-
EPS (Basic)	192.51	181.11	150.19	82.31	137.63
EPS (Diluted)	192.51	181.11	150.19	82.31	137.63
EPS Growth	6.29%	20.59%	82.47%	-40.20%	3.82%

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Free Cash Flow	13,458	12,372	16,888	14,496	7,721
Free Cash Flow Per Share	112.55	103.48	141.24	121.24	64.58
Dividend Per Share	53.000	45.000	40.000	25.000	34.000
Dividend Growth	17.78%	12.50%	60.00%	-26.47%	13.33%
Gross Margin	65.38%	62.01%	60.02%	56.72%	59.75%
Operating Margin	17.83%	16.60%	15.53%	11.38%	16.39%
Profit Margin	15.65%	16.70%	14.18%	8.48%	15.47%
Free Cash Flow Margin	9.15%	9.54%	13.33%	12.50%	7.26%
EBITDA	30,052	24,619	22,268	15,893	20,122
EBITDA Margin	20.43%	18.99%	17.58%	13.70%	18.92%
D&A For EBITDA	3,821	3,101	2,592	2,697	2,690
EBIT	26,232	21,518	19,676	13,196	17,432
EBIT Margin	17.83%	16.60%	15.53%	11.38%	16.39%
Effective Tax Rate	18.05%	12.31%	10.46%	22.84%	8.89%
Revenue as Reported	152,956	134,583	129,784	118,153	107,968